Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
LINKBAL, First Half Ordinary Profit Turns to Profit, Jan-Mar Ordinary Profit Loss Narrows
6046 LINKBAL INC. 【J-GAAP】
Earnings ReportLINKBAL INC. <6046> [TSE Std] announced its financial results after the market closed on May 11th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending September 2026 (October 2025 to March 2026) turned into a profit of 2 million yen (compared to a loss of 62 million yen in the same period last year). Progress toward the full-year plan of 2 million yen was 100.0%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the April to September period (second half) is expected to turn into a break even (compared to a loss of 21 million yen in the same period last year).
In the most recent three-month period, from January to March (2Q), the consolidated ordinary loss improved to a deficit of 9 million yen (compared to a loss of 36 million yen in the same period last year). The operating profit/loss margin drastically improved from -16.9% in the same period last year to -4.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2023 | 485 | -81 | -81 | -83 | -4.5 | ー | May 10, 2024 | J-GAAP |
| Oct - Mar, 2024 | 442 | -62 | -62 | -64 | -3.5 | ー | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 | 493 | 0 | 2 | 1 | 0.1 | 100.0 | May 11, 2026 | J-GAAP |
| YoY | +11.5% | - | - | - | - |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2025 Guidance | ー | ー | ー | ー | - | 0 | Nov 7, 2025 | J-GAAP |
| Oct - Mar, 2025 Results | 493 | 0 | 2 | 1 | 0.1 | 0 | May 11, 2026 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 | 464 | -27 | -21 | -133 | -7.1 | 0 | Nov 7, 2025 | J-GAAP |
| Apr - Sep, 2026 Guidance | 478 | 2 | 0 | 0 | 0.0 | 0 | May 11, 2026 | J-GAAP |
| YoY | +3.0% | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2024 | 968 | -123 | -123 | -124 | -6.7 | 0 | Nov 8, 2024 | J-GAAP |
| Sep, 2025 | 906 | -89 | -83 | -197 | -10.6 | 0 | Nov 7, 2025 | J-GAAP |
| Sep, 2026 Guidance | 971 | 2 | 2 | 1 | 0.1 | 0 | Nov 7, 2025 | J-GAAP |
| YoY | +7.2% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2025 | 213 | -36 | -36 | -36 | -2.0 | -16.9 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 225 | -32 | -29 | -144 | -7.7 | -14.2 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 239 | 5 | 8 | 11 | 0.6 | 2.1 | Nov 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 258 | 11 | 11 | 10 | 0.6 | 4.3 | Feb 9, 2026 | J-GAAP |
| Jan - Mar, 2026 | 235 | -11 | -9 | -9 | -0.9 | -4.7 | May 11, 2026 | J-GAAP |
| YoY | +10.3% | +69.4% | +75.0% | +75.0% | +53.8% |
Related Articles
MT GENEX, 43% Increase in Ordinary Profit, Record High for The First Time in Sixteen Years
AUTOBACS SEVEN, 3% Increase in Ordinary Profit for The Current Fiscal Year
ZETA INC, Jan-Mar (1Q) Ordinary Profit Turns to Loss
ASKA Pharma, 8% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 5 Yen, This Fiscal Year to Increase Dividend by 5 Yen
DAIICHI SANKYO, 0.05% Increase in Net Income for The Current Fiscal Year, Dividend Raised by 22 Yen
Integral, Jan-Mar (1Q) Net Income Turns to Profit
PIETRO, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 4.4 times
TOWA PHARMA, Ordinary Profit Forecast for Last Fiscal Year Revised Upward to an Unexpected 7% Increase, Raises Record High Profit
SHO-BOND, Jan-Mar (3Q) Ordinary Profit Increases by 16%
Interspace, Ordinary Profit Forecast for First Half Revised Upward by 55%